DK0715624T3 - Fremgangsmåde til fremstilling af benzodiazepinforbindelser, som er anvendelige som antagonister for CCk eller gastrin - Google Patents

Fremgangsmåde til fremstilling af benzodiazepinforbindelser, som er anvendelige som antagonister for CCk eller gastrin

Info

Publication number
DK0715624T3
DK0715624T3 DK94924368T DK94924368T DK0715624T3 DK 0715624 T3 DK0715624 T3 DK 0715624T3 DK 94924368 T DK94924368 T DK 94924368T DK 94924368 T DK94924368 T DK 94924368T DK 0715624 T3 DK0715624 T3 DK 0715624T3
Authority
DK
Denmark
Prior art keywords
pct
gastrin
cck
date
antagonists
Prior art date
Application number
DK94924368T
Other languages
Danish (da)
English (en)
Inventor
Michael Szelke
Mitsuaki Ohta
Keiji Miyata
Graeme Semple
Hamish Ryder
Masato Satoh
Akito Nishida
Masato Ishii
Original Assignee
Yamanouchi Pharma Co Ltd
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd, Ferring Bv filed Critical Yamanouchi Pharma Co Ltd
Application granted granted Critical
Publication of DK0715624T3 publication Critical patent/DK0715624T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Fats And Perfumes (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Lubricants (AREA)
DK94924368T 1993-08-25 1994-08-25 Fremgangsmåde til fremstilling af benzodiazepinforbindelser, som er anvendelige som antagonister for CCk eller gastrin DK0715624T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9317693A GB2282595A (en) 1993-08-25 1993-08-25 Benzodiazepine derivatives
PCT/GB1994/001859 WO1995006040A1 (en) 1993-08-25 1994-08-25 Benzodiazepine compounds useful as antagonists of cck or of gastrine

Publications (1)

Publication Number Publication Date
DK0715624T3 true DK0715624T3 (da) 1999-01-11

Family

ID=10741026

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94924368T DK0715624T3 (da) 1993-08-25 1994-08-25 Fremgangsmåde til fremstilling af benzodiazepinforbindelser, som er anvendelige som antagonister for CCk eller gastrin

Country Status (21)

Country Link
US (1) US5728829A (xx)
EP (1) EP0715624B1 (xx)
JP (1) JPH09504005A (xx)
KR (1) KR960703873A (xx)
CN (1) CN1129442A (xx)
AT (1) ATE164840T1 (xx)
AU (1) AU687433B2 (xx)
CA (1) CA2169089A1 (xx)
CZ (1) CZ53096A3 (xx)
DE (1) DE69409534T2 (xx)
DK (1) DK0715624T3 (xx)
ES (1) ES2117797T3 (xx)
FI (1) FI960836A (xx)
GB (1) GB2282595A (xx)
HU (1) HUT73978A (xx)
IL (1) IL110783A0 (xx)
NO (1) NO960747L (xx)
NZ (1) NZ271131A (xx)
PL (1) PL313165A1 (xx)
WO (1) WO1995006040A1 (xx)
ZA (1) ZA946474B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0948495T3 (da) * 1996-11-19 2004-06-01 Amgen Inc Aryl- og heteroarylsubstitueret, kondenseret pyrrol som antiinflammatoriske midler
ATE248823T1 (de) * 1996-12-10 2003-09-15 Zeria Pharm Co Ltd 1,5-benzodiazepinderivate
FR2782997A1 (fr) * 1998-09-08 2000-03-10 Hoechst Marion Roussel Inc Nouveaux derives de la benzodiazepinone, procede de preparation et intermediaires de ce procede, application a titre de medicaments et compositions pharmaceutiques les renfermant
US20040138207A1 (en) * 2001-05-11 2004-07-15 Mayumi Yamano Antitumor agents
GB0221923D0 (en) * 2002-09-20 2002-10-30 Arrow Therapeutics Ltd Chemical compounds
CA2529227A1 (en) * 2003-06-26 2005-01-06 Merck & Co., Inc. Benzodiazepine cgrp receptor antagonists
JP5197361B2 (ja) * 2005-06-06 2013-05-15 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティー オブ イリノイ 睡眠障害を処置するための組成物および方法
RU2693484C1 (ru) 2013-11-22 2019-07-03 СиЭль БАЙОСАЕНСИЗ ЭлЭлСи Антагонисты гастрина для лечения и профилактики остеопороза
GB201414116D0 (en) * 2014-08-08 2014-09-24 Trio Medicines Ltd Benzodiazepine derivatives
GB201513979D0 (en) 2015-08-07 2015-09-23 Trio Medicines Ltd Synthesis of benzodiazepine derivatives
US10881667B2 (en) 2018-10-30 2021-01-05 City University Of Hong Kong Method and composition for treating epilepsy
CN109553591B (zh) * 2019-01-15 2020-12-15 山东安信制药有限公司 一种富马酸喹硫平中间体的制备方法
US11285161B2 (en) 2019-04-26 2022-03-29 City University Of Hong Kong Method and composition for treating mental disorder and pain associated with nerve damage
FR3097222B1 (fr) * 2019-06-11 2021-05-28 Michelin & Cie Nouveaux composes 1,3-dipolaires comprenant un heterocycle aromatique et un cycle imidazole

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820834A (en) * 1984-06-26 1989-04-11 Merck & Co., Inc. Benzodiazepine analogs
IL96613A0 (en) * 1989-12-18 1991-09-16 Merck & Co Inc Pharmaceutical compositions containing benzodiazepine analogs
CA2099672A1 (en) * 1990-12-25 1992-06-26 Masato Satoh Benzodiazepine derivatives
GB9116113D0 (en) * 1991-07-25 1991-09-11 Merck Sharp & Dohme Therapeutic agents
FR2682381B1 (fr) * 1991-10-10 1995-04-07 Rhone Poulenc Rorer Sa Derives de benzodiazepine, leur preparation et les medicaments les contenant.
WO1993007131A1 (en) * 1991-10-10 1993-04-15 Merck Sharp & Dohme Limited Benzodiazepine derivatives and their use as antagonists of cholecystokinin and/or gastrin receptors
AU2759692A (en) * 1991-10-24 1993-05-21 Glaxo Group Limited Benzodiazepine derivatives as antagonists of gastrin and/or cholecystokinin
IL104853A (en) * 1992-02-27 1997-11-20 Yamanouchi Pharma Co Ltd Benzodiazepine derivatives, their preparation and pharmaceutical compositions containing them
GB2264492B (en) * 1992-02-27 1996-09-25 Yamanouchi Pharma Co Ltd Benzodiazepine derivatives
EP0647632A1 (en) * 1992-06-24 1995-04-12 Yamanouchi Pharmaceutical Co. Ltd. Novel benzodiazepine derivative

Also Published As

Publication number Publication date
WO1995006040A1 (en) 1995-03-02
US5728829A (en) 1998-03-17
GB2282595A (en) 1995-04-12
AU687433B2 (en) 1998-02-26
KR960703873A (ko) 1996-08-31
ZA946474B (en) 1996-03-25
GB9317693D0 (en) 1993-10-13
DE69409534T2 (de) 1998-08-06
CZ53096A3 (en) 1996-09-11
HUT73978A (en) 1996-10-28
AU7466194A (en) 1995-03-21
EP0715624A1 (en) 1996-06-12
DE69409534D1 (de) 1998-05-14
HU9600205D0 (en) 1996-04-29
PL313165A1 (en) 1996-06-10
FI960836A0 (fi) 1996-02-23
ATE164840T1 (de) 1998-04-15
NO960747L (no) 1996-04-25
FI960836A (fi) 1996-04-22
NZ271131A (en) 1997-11-24
EP0715624B1 (en) 1998-04-08
IL110783A0 (en) 1994-11-11
JPH09504005A (ja) 1997-04-22
ES2117797T3 (es) 1998-08-16
CA2169089A1 (en) 1995-03-02
CN1129442A (zh) 1996-08-21
NO960747D0 (no) 1996-02-23

Similar Documents

Publication Publication Date Title
DK0715624T3 (da) Fremgangsmåde til fremstilling af benzodiazepinforbindelser, som er anvendelige som antagonister for CCk eller gastrin
ES2119160T3 (es) Derivados de tiazolidina, su preparacion y los medicamentos que les contienen.
DE69530081D1 (de) Gastrin- und cck-antagonisten
DE69828445D1 (de) Heterozyklische verbindungen,und deren verwendung in arzneimittel,verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
FI962494A (fi) 5-(2-imidatsolinyyliamino)bentsimidatsolijohdannaisia, niiden valmistus ja niiden käyttö alpha-2-adrenoseptoriagonisteina
MX9205817A (es) Derivados de benzodiazepina, procedimiento para supreparacion y medicamentos que los contienen
SE8505715L (sv) Indolderivat
RU94038255A (ru) Производные бензодиазепина, способ их получения, фармацевтическая композиция
MX9205207A (es) Derivados de dihidropiridina, procedimiento para su preparacion y composicion farmaceutica que los comprende
IL113365A (en) 5-Heterocyclo-1,5-benzodiazepine derivatives their preparation and pharmaceutical compositions containing them
DK0813411T3 (da) Anvendelse af vincopetinderivater til hæmning af dannelse eller afsondring af amyloid -protein
FI803237L (fi) 6,7-bensomorfanderivat foerfaranden foer deras framstaellning farmaceutiska sammansaettningar innehaollande naemnda derivat och deras anvaendning som laekemedel
DK0678089T3 (da) N-Acylpyrrolidiner og lægemidler til behandling eller forebyggelse af cholecystokinin- og gastrin-relaterede forstyrrelser
TW221993B (xx)
GB9318790D0 (en) Heterocyclic derivatives
DE3266521D1 (en) 2-acylaminomethyl-1,4-benzodiazepine derivatives, their preparation and intermediates, and pharmaceutical preparations containing them
DE69334353D1 (de) Benzodiazepin-Derivate, verwendbar als CCK-Rezeptor Antagonisten
ATE49601T1 (de) Neue 11-piperazinyl-5h-imidazo(2,1c>(1,4>benzodiazepine, verfahren zu ihrer herstellung und zwischenprodukte und erstere enthaltende arzneimittel.
ATE67760T1 (de) In stellung 2 substituierte monoaryl-5 astriazinone, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DK573981A (da) Fremgangsmaade til fremstilling af cis-c-3",c4"-carbonatderivater af o-demethyl-oleandomycin og mellemprodukter herfor
TH18598A (th) อนุพันธ์ 1,5-เบนโซไดอะเซฟีน
TH18598EX (th) อนุพันธ์ 1,5-เบนโซไดอะเซฟีน